cefuroxime has been researched along with Cardiovascular Diseases in 5 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective, multicentre, randomized, open-label, parallel group study compared the efficacy, safety and tolerability of cefuroxime 750 mg iv administered either twice daily (bd) or three times daily (tds) for 48-72 h, followed by oral cefuroxime axetil 500 mg bd for 5-7 days in a sequential therapy regimen for the treatment of acute exacerbations of chronic bronchitis." | 9.08 | Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis. ( Droszcz, W; Marr, C; Reisenberg, K; Staley, H; Vogel, F; Vondra, V, 1997) |
| "A prospective, multicentre, randomized, open-label, parallel group study compared the efficacy, safety and tolerability of cefuroxime 750 mg iv administered either twice daily (bd) or three times daily (tds) for 48-72 h, followed by oral cefuroxime axetil 500 mg bd for 5-7 days in a sequential therapy regimen for the treatment of acute exacerbations of chronic bronchitis." | 5.08 | Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis. ( Droszcz, W; Marr, C; Reisenberg, K; Staley, H; Vogel, F; Vondra, V, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knoderer, CA | 1 |
| Cox, EG | 1 |
| Berg, MD | 1 |
| Webster, AH | 1 |
| Turrentine, MW | 1 |
| Geroulanos, S | 2 |
| Oxelbark, S | 2 |
| Turina, M | 2 |
| Vogel, F | 1 |
| Droszcz, W | 1 |
| Vondra, V | 1 |
| Reisenberg, K | 1 |
| Marr, C | 1 |
| Staley, H | 1 |
| Donfried, B | 1 |
| Recker, F | 1 |
| de Riberolles, C | 1 |
| Bailly, P | 1 |
4 trials available for cefuroxime and Cardiovascular Diseases
| Article | Year |
|---|---|
[A prospective, randomized comparative study between cefazolin and cefuroxime as perioperative antibiotic prevention in cardiovascular surgery].
Topics: Adolescent; Adult; Aged; Blood Vessel Prosthesis; Cardiovascular Diseases; Cefazolin; Cefuroxime; Ce | 1984 |
Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bronchitis; Cardiovascular Diseases; Cefuroxim | 1997 |
Antimicrobial prophylaxis in cardiovascular surgery.
Topics: Anti-Bacterial Agents; Blood Vessel Prosthesis; Cardiovascular Diseases; Cefazolin; Ceftriaxone; Cef | 1987 |
[Peroperative antibioprevention with cefuroxime in cardiovascular surgery].
Topics: Bacterial Infections; Cardiovascular Diseases; Cefuroxime; Cephalosporins; Clinical Trials as Topic; | 1987 |
1 other study available for cefuroxime and Cardiovascular Diseases
| Article | Year |
|---|---|
Efficacy of limited cefuroxime prophylaxis in pediatric patients after cardiovascular surgery.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiovascular Diseases; Cefuroxime; Chil | 2011 |